Workshop report: Malaria vaccine development in Europe--preparing for the future
Nicola K Viebig1, Flavia D'Alessio1, Simon J Draper2
1European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany.
Vaccine
|October 4, 2015
Summary
Developing a safe and effective malaria vaccine is crucial for controlling malaria and reducing deaths. The 2030 Malaria Vaccine Technology Roadmap guides future vaccine development, with European strategies discussed for global impact.
Area of Science:
- Global Health
- Vaccinology
- Infectious Disease Control
Background:
- Malaria remains a significant global health challenge, causing substantial mortality.
- A safe and effective malaria vaccine is a critical tool for disease control.
- The 2030 Malaria Vaccine Technology Roadmap outlines updated goals for vaccine development.
Purpose of the Study:
- To discuss European strategies for advancing malaria vaccine development.
- To align European efforts with global malaria control priorities.
- To guide researchers, policymakers, and funders in achieving roadmap goals.
Main Methods:
- A workshop was convened in Brussels in November 2014.
- Key stakeholders from European, North American, and African malaria vaccine communities participated.
- Discussions focused on European strategies within the global context of malaria vaccine development.
Main Results:
- Key players engaged in strategic discussions on future malaria vaccine development.
- Recommendations were formulated by the European malaria community.
- The workshop aimed to foster collaboration and guide future research and development.
Conclusions:
- European strategies are essential for advancing global malaria vaccine development.
- The recommendations should inform researchers, policymakers, and funders.
- Collaborative efforts are needed to meet the ambitious goals of the Malaria Vaccine Technology Roadmap.
Related Concept Videos
01:23Vaccine Production
57
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
57
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K